Metastatic Pancreas Cancer
4 clinical trials · Condition
◉ Watch Metastatic Pancreas Cancer
| Record | Firm | Date |
|---|---|---|
| Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer (NCT04897854) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-04-22 |
| EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX (NCT03126435) | SynCore Biotechnology Co., Ltd. | 2018-10-16 |
| Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598) (NCT02885727) | University of Maryland, Baltimore | 2017-07-01 |
| A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer (NCT01586611) | AHS Cancer Control Alberta | 2012-06-01 |
Track Metastatic Pancreas Cancer automatically
Every clearance here is in the API, with alerts when new ones post.